Is Pfizer Stock a Buy or Sell After Recent Dip? PFE Stock Analysis → 8,788% Return Predicted For THIS Crypto (already up 40% in 6 months) (From Paradigm Press) (Ad) Hosted by MarketBeat StaffMarch 29, 2023 Share Share Play video for Is Pfizer Stock a Buy or Sell After Recent Dip? PFE Stock AnalysisDetailsGuestsIn this video, we discuss whether it's a good time for investors to buy into Pfizer's stock after its recent dip. The conversation covers Pfizer's past performance, the recent acquisition of Seagen, and its potential growth in the oncology field. Chris provides an objective analysis of Pfizer's fundamentals and earnings estimates for next year and discusses the market's current valuation.Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioPFEPfizer4.9822 of 5 stars$27.94-0.7%6.01%77.61SGENSeagen0.2745 of 5 stars$228.740%N/A-57.04 Compare These Stocks Add These Stocks to My Watchlist Chris Markoch, GuestMarketBeat Contributor, MarketBeatChris Markoch is a freelance financial copywriter with over five years of experience covering various aspects of the financial markets. You may find his writing a little different than other stock articles you’ve read. And that’s OK with him. Chris doesn’t have a traditional finance background. What he does bring to the table is a strong business and marketing background having worked for agencies that serviced Fortune 500 companies. With that in mind, he isn’t overly impressed with what companies say, and more focused on what they do. And because buyer behavior dictates so much of what happens with a stock, Chris always keeps the end consumer close in mind. Chris has been writing for MarketBeat since 2018.Laycee Kluin, HostDigital Marketing Strategist, MarketBeatAs MarketBeat's Digital Marketing Strategist, Laycee helps with the marketing side of tasks including developing email campaigns, running the promotion of the MarketBeat products and exploring social media opportunities. She felt called to the Marketing industry because she enjoys collaborating with people and making connections. The University of Sioux Falls alum majored in Media Studies with minors in Communications and Spanish. Laycee brings a background in Financial Services Marketing.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube More From MarketBeatCentral Bank Gold Heist In Progressfrom Colonial Metals7 Stocks That Don’t Need an AI Boost to Move Higherfrom MarketBeatLike Tiny Crypto Retirement Fundsfrom Crypto 101 Media15 REITs That Wall Street Analysts Love in Today's Marketfrom MarketBeatMake This $3 Trade the Instant the Opening Bell Ringsfrom Monument Traders Alliance7 Uranium Stocks That Can Fuel a Growth Portfolio in 2024from MarketBeat 7 Stocks to Help You Build Off January’s GainsIt's frequently said that as January goes, so goes the market. If that's the case, it's time for investors to put money to work in the stock market.Recent VideosCrafting Your Portfolio's Magnificent Seven: Top Stocks for 2024Reddit IPO: Game-Changer or Meme Stock in the Making?Oracle Stock Skyrockets by 15% Featured Articles and OffersDefense Contractor Stocks Explained, Plus Investment GuidePosted March 14, 2024View Defense Contractor Stocks Explained, Plus Investment GuideThe only AI company you should be looking atFrom Behind the Markets(Ad)View The only AI company you should be looking at$5 Billion Boost for Taiwan Semiconductor Aids Nvidia ExpansionPosted March 14, 2024View $5 Billion Boost for Taiwan Semiconductor Aids Nvidia Expansion4 Oversold Large Cap Stocks Yielding High DividendsPosted March 14, 2024View 4 Oversold Large Cap Stocks Yielding High DividendsActive Rebound: 2 Discrete Semiconductor Stocks Making MovesPosted March 12, 2024View Active Rebound: 2 Discrete Semiconductor Stocks Making MovesCentral Bank Gold Heist In ProgressFrom Colonial Metals(Ad)View Central Bank Gold Heist In Progress Search Videos: Search Articles Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hosted by MarketBeat StaffMarch 29, 2023 Share Share Play video for Is Pfizer Stock a Buy or Sell After Recent Dip? PFE Stock AnalysisDetailsGuestsIn this video, we discuss whether it's a good time for investors to buy into Pfizer's stock after its recent dip. The conversation covers Pfizer's past performance, the recent acquisition of Seagen, and its potential growth in the oncology field. Chris provides an objective analysis of Pfizer's fundamentals and earnings estimates for next year and discusses the market's current valuation.Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioPFEPfizer4.9822 of 5 stars$27.94-0.7%6.01%77.61SGENSeagen0.2745 of 5 stars$228.740%N/A-57.04 Compare These Stocks Add These Stocks to My Watchlist Chris Markoch, GuestMarketBeat Contributor, MarketBeatChris Markoch is a freelance financial copywriter with over five years of experience covering various aspects of the financial markets. You may find his writing a little different than other stock articles you’ve read. And that’s OK with him. Chris doesn’t have a traditional finance background. What he does bring to the table is a strong business and marketing background having worked for agencies that serviced Fortune 500 companies. With that in mind, he isn’t overly impressed with what companies say, and more focused on what they do. And because buyer behavior dictates so much of what happens with a stock, Chris always keeps the end consumer close in mind. Chris has been writing for MarketBeat since 2018.Laycee Kluin, HostDigital Marketing Strategist, MarketBeatAs MarketBeat's Digital Marketing Strategist, Laycee helps with the marketing side of tasks including developing email campaigns, running the promotion of the MarketBeat products and exploring social media opportunities. She felt called to the Marketing industry because she enjoys collaborating with people and making connections. The University of Sioux Falls alum majored in Media Studies with minors in Communications and Spanish. Laycee brings a background in Financial Services Marketing.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube More From MarketBeatCentral Bank Gold Heist In Progressfrom Colonial Metals7 Stocks That Don’t Need an AI Boost to Move Higherfrom MarketBeatLike Tiny Crypto Retirement Fundsfrom Crypto 101 Media15 REITs That Wall Street Analysts Love in Today's Marketfrom MarketBeatMake This $3 Trade the Instant the Opening Bell Ringsfrom Monument Traders Alliance7 Uranium Stocks That Can Fuel a Growth Portfolio in 2024from MarketBeat